Managed Healthcare Executive19h
MHE Week in Review – New Medicare Proposal, Trump’s NIH Director Nominee and More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...
Managed Healthcare Executive23h
The Need to Enhance Diagnosis and Treatment for Pulmonary Hypertension-ILD Patients Across Europe
Two industry-sponsored studies investiaged needs of people with pulmonary hypertesion and interstitial lung disease.
Managed Healthcare Executive2d
The Benefits of Self-Insurance and ERISA’s Role in Employer Health Plans
Paul Fronstin, director of Health Benefits Research at EBRI, discussed ERISA and trends in employer self-insurance during a ...
Managed Healthcare Executive3d
Drew Kearney, JD
ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...
Managed Healthcare Executive3d
Mike Sutten
ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...
Managed Healthcare Executive3d
Joanna Craver DiBenedetto, BS, MNM
ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...
Managed Healthcare Executive3d
Dennis A. Robbins, PhD, MPH
ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...
Managed Healthcare Executive4d
Daniel Knecht
ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...
Managed Healthcare Executive4d
Julie Malida
ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...
Managed Healthcare Executive4d
Dan Danielson MS, RPh
ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...
Managed Healthcare Executive4d
Jared Safran
ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...